Granted Patent
B2
US 7,737,256 · App. 10/470,245 · Granted Jun 15, 2010
Antibody against uPA/uPAR
View Patent ↗
Loading inventors, assignments & file history…
Abstract
The invention herein disclosed relates to the anti-HIV action of uPAR-activators or activated uPAR molecules, the control of chemotaxis and cell migration by agents interfering with uPAR activation, a method for determining activated uPAR forms, the use of agents interfering with uPA/uPAR interaction for the diagnosis or therapy of diseases.
Claims (2)
1. Antibody against a uPAR fragment, wherein the uPAR fragment consists only of a member selected from the group consisting of peptides AVTYSRSRYLEC [SEQ ID NO: 1], VTYSRSRYLEC [SEQ ID NO: 5], TYSRSRYLEC [SEQ ID NO: 6], and YSRSRYLEC [SEQ ID NO: 7].
2. Antibody against a uPAR fragment, wherein the uPAR fragment consists only of peptide AVTYSRSRYLEC [SEQ ID NO: 1].
Assignments (3)
RELEASE OF SECURITY INTEREST AT REEL/FRAME 068770/0632
Recorded Dec 19, 2024
From: JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT
To: OUTDOOR WIRELESS NETWORKS LLC
Reel/Frame 069743/0264 →
TRANSFER OF BUSINESS
Recorded Feb 5, 2013
From: FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR
To: OSPEDALE SAN RAFFAELE S.R.L.
Reel/Frame 029752/0277 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Apr 1, 2010
From: BLASI, FRANCESCO; SIDENIUS, NICOLAI; RESNATI, MASSIMO; MONDINO, ANNA; POLI, GUIDO; ALFANO, MASSIMO
To: FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR
Reel/Frame 024175/0934 →
Continuity (2)
Provisional Application
6026319800
· Jan 25, 2001